Medtronic, Inc. receives Investment Bank Analyst Rating Update
- ByInvesting.com-
Medtronic (NYSE:MDT) shares dipped in premarket Thursday after the medical device company delivered softer-than-expected guidance. Medtronic posted adjusted EPS of $1.57 on...
Investing.com - Medtronic (NYSE: MDT) reported fourth quarter EPS of $1.57, $0.02 better than the analyst estimate of $1.55. Revenue for the quarter came in at $8.5B versus the...
Medtronic (NYSE:MDT) shares are up over 3% Monday after the United States Food and Drug Administration (FDA) approved the MiniMed 780G insulin pump system for modifications to...
By Senad Karaahmetovic UBS analysts double-downgraded Medtronic (NYSE:MDT) shares to Sell from Buy on near-term sales and EPS downside risk. They believe the ongoing...
By Geoffrey Smith Investing.com -- Medtronic (NYSE:MDT) stock rose in premarket trading on Tuesday after the maker of medical devices promised solid organic sales growth and...
Medtronic (NYSE:MDT) reported Q3 EPS of $1.30, $0.03 better than the analyst estimate of $1.27. Revenue for the quarter came in at $7.7 billion versus the consensus estimate of...